Inconsistent engraftment of luciferase-expressing tumors, especially GL261 Red-FLuc, has been reported in the recent literature. However, techniques to improve tumor take have not been described. Our study aimed to optimize two luciferase-expressing mouse glioblastoma models, GL261 Red-FLuc and TRP-mCherry-FLuc, which revealed differences in tumor development and characteristics. Congratulations Louis!

Brayden featured in UKNow for CURE Fellowship
UKNow recently featured Brayden’s selection for the 2026 Commonwealth Undergraduate Research Experience (CURE) Fellowship program. As part of the fellowship, Brayden will conduct summer research in the BHL and present his work at the Summer Research Symposium on August 25. You can read the full story HERE.


